Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia

Br J Haematol. 2019 Nov;187(4):543-545. doi: 10.1111/bjh.16245. Epub 2019 Oct 4.
No abstract available

Keywords: blastic phase CML; dasatinib; sudden blastic transformation; treatment-free remission; tyrosine kinase inhibitor.

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Lymphocyte Activation*
  • Middle Aged
  • Protein Kinase Inhibitors / therapeutic use
  • Remission Induction / methods
  • Withholding Treatment

Substances

  • Protein Kinase Inhibitors